Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	14.85B +21.7%
Revenue (ttm)	5.36B +9.0%
Net Income	722.87M +3.7%
EPS	0.82 +5.8%
Shares Out	881.71M
PE Ratio	20.57
Forward PE	13.58
Dividend	0.40 (2.35%)
Ex-Dividend Date	Sep 8, 2025

Volume	16,095,100
Average Volume	14,208,561
Open	17.16
Previous Close	16.84
Day's Range	16.97 - 17.38
52-Week Range	11.90 - 22.25
Beta	0.30
RSI	53.03
Earnings Date	Apr 24, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 5,001
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2024, SHA:603456's revenue was 5.16 billion, a decrease of -6.57% compared to the previous year's 5.52 billion. Earnings were 606.10 million, a decrease of -41.34%.